A potential hypothesis for 2019-nCoV infection therapy through delivery of recombinant ACE2 by red blood cell-hitchhiking
Abstract A novel infectious disease, caused by 2019 Novel Coronavirus (2019-nCoV) is responsible for the recent outbreak of severe respiratory disease. The 2019-nCoV spread rapidly and reaching epidemic proportions in many countries of the world. ACE2 was identified as a key receptor for 2019-nCoV i...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Aristotle University of Thessaloniki
2020-12-01
|
| Series: | Journal of Biological Research - Thessaloniki |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40709-020-00129-y |